News | October 27, 2025
Sigachi Industries posts Q2 FY2026 consolidated profit at Rs. 10.68 Cr
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Dr Reddys Laboratories has reported total income of Rs. 8,805.1 crore during the period ended September 30, 2025
With milestone-linked funding of Rs. 5–25 crore per project (and up to Rs. 50 crore in exceptional cases), the Mission will support projects that bring impactful MedTech solutions to market
Long-term OGSIVEO treatment for up to four years associated with further tumor reductions, increased objective response rate, sustained symptom improvement, and consistent safety profile
INEOS production of BDO in Germany, which produces a vital ingredient for antibiotics, statins and vitamin B6, is being crushed by a flood of carbon heavy imports and product dumping from the Far East
Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025
The product is indicated for the chronic management of patients with Urea Cycle Disorders
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
Results from the Phase 2 PHAROS trial potentially establish new benchmark with targeted combination therapies for this patient population
Subscribe To Our Newsletter & Stay Updated
